BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19035856)

  • 1. Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
    Kirby RS; Fitzpatrick JM
    BJU Int; 2008 Dec; 102(11):1492-3. PubMed ID: 19035856
    [No Abstract]   [Full Text] [Related]  

  • 2. Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
    Parker C; Graham J
    BJU Int; 2009 Feb; 103(4):554. PubMed ID: 19187350
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-based medicine in prostate cancer: where do we stand in 2006?
    Dahm P
    Curr Opin Urol; 2006 May; 16(3):162-7. PubMed ID: 16679853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute for Clinical Excellence Guideline on prostate cancer and the future of cryotherapy.
    Kirby R; Fitzpatrick J
    BJU Int; 2009 Jan; 103(2):146-7. PubMed ID: 19021627
    [No Abstract]   [Full Text] [Related]  

  • 5. Urological cancer guidelines: are there any differences?
    Meyer JP; Sullivan ME; Bell RC
    BJU Int; 2006 Nov; 98(5):940-1. PubMed ID: 17034592
    [No Abstract]   [Full Text] [Related]  

  • 6. Updating the prostate cancer guidelines.
    Mohler JL
    J Natl Compr Canc Netw; 2007 Aug; 5(7):647-8. PubMed ID: 17726824
    [No Abstract]   [Full Text] [Related]  

  • 7. Final outcomes of patients with low-risk prostate cancer suitable for active surveillance but treated surgically.
    Louie-Johnsun M; Neill M; Treurnicht K; Jarmulowicz M; Eden C
    BJU Int; 2009 Nov; 104(10):1501-4. PubMed ID: 19426187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based medicine, conscience-based medicine, and the management of low-risk prostate cancer.
    Zietman A
    J Clin Oncol; 2009 Oct; 27(30):4935-6. PubMed ID: 19720880
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostate cancer: interpretation of management guidelines].
    Ploussard G; Desgrandchamps F
    Rev Prat; 2013 Apr; 63(4):515-20. PubMed ID: 23682482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for defining and treating high risk localized prostate cancer.
    Thompson IM; Carroll PR; Carducci MA
    J Urol; 2006 Dec; 176(6 Pt 2):S6-S10; quiz S3-5. PubMed ID: 17084170
    [No Abstract]   [Full Text] [Related]  

  • 12. A critical need for national guidelines.
    Osanto S; van Poppel H
    Onkologie; 2010; 33(7):351-2. PubMed ID: 20631480
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate specific antigen best practice statement: 2009 update.
    Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
    J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer.
    J Natl Compr Canc Netw; 2011 May; 9(5):xxxvii-xlii. PubMed ID: 21739727
    [No Abstract]   [Full Text] [Related]  

  • 15. [New guideline for prostate carcinoma].
    Wirth M
    Urologe A; 2010 Feb; 49(2):171-2. PubMed ID: 20180055
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials.
    Nanda A; D'Amico AV
    BJU Int; 2008 Nov; 102(10):1366-8. PubMed ID: 18778343
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-based medicine and practice guidelines: application to genetics.
    Toriello HV; Goldenberg P
    Am J Med Genet C Semin Med Genet; 2009 Aug; 151C(3):235-40. PubMed ID: 19621463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: epidemiology and health-related quality of life.
    Penson DF; Rossignol M; Sartor AO; Scardino PT; Abenhaim LL
    Urology; 2008 Dec; 72(6 Suppl):S3-11. PubMed ID: 19095126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
    Ito K
    Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Institute for Health and Clinical Excellence guidelines on preoperative tests: the use of routine preoperative tests for elective surgery.
    Reynolds TM; ;
    Ann Clin Biochem; 2006 Jan; 43(Pt 1):13-6. PubMed ID: 16390604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.